The Cliniporator device has been developed and is manufactured by IGEA (Carpi, Italy). The drug used in most treatments is Bleomycin, a well-known drug in oncology. It’s highly effective and toxic, killing the cancer cells once entered into the cells. However, due to its large size, it cannot enter through the cell membrane by itself and has been considered inefficient. With the combination of electroporation, this drug has now become a very effective anti-cancer drug. Electroporation temporarily opens up small pathways (pores) in the cell membrane barrier by using very brief, intense electrical pulses.
The Cliniporator is used to fight cutaneous and sub-cuteaneous metastasies by increasing the effect of chemotherapeutic drugs, and is said to be a very good alternative to traditional radiation therapy and surgery.
Anders Johnsson, managing director of iClin Solutions, said: “The Cliniporator treats cancer of any histological type in a quick and efficient manner. Not only will the device increase the effect of these drugs, it also requires a much smaller dose, minimizing the risk of complications. Since the treatment can be done on out-patient basis, it will save cost compared to radiation therapy or surgery.”